CEA-TCB activity was found to be strongly correlated with CEA expression, with a higher potency observed in highly CEA-expressing tumor cells, with a threshold of 10,000 CEA-binding sites/cell (39). The gene discussed is CEACAM5; the disease is neoplasm.